CD274 and triple-negative breast carcinoma: Furthermore, combining an estrogen antagonist with anti-PD-L1 antibody treatment in murine 4T1 triple negative breast cancer cells implanted into the mammary glands of mice showed an enhanced reduction in tumor growth compared to antiestrogen treatment alone, while anti-PD-L1 alone had no effect (136).